Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annett Mueller

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Emerging Topics in Life Sciences|February 1, 2021
Using genome editing to engineer universal plateletsMoyra Lawrence, Annett Mueller, Cedric Ghevaert
Immunologic Research|April 4, 2017
Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in gliomaSusan Brandenburg, Kati Turkowski, Annett Mueller, et al.
Cancer Chemotherapy and Pharmacology|May 1, 2012
Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell linesAnnett Mueller, Erika Bachmann, Monika Linnig, et al.
Glia|September 27, 2017
VEGF as a modulator of the innate immune response in glioblastomaKati Turkowski, Susan Brandenburg, Annett Mueller, et al.
International Journal of Cancer|December 30, 2009
Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathwaysOrestis Lyros, Annett Mueller, Florian Heidel, et al.
World Journal of Gastroenterology|July 19, 2008
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximabMarkus Moehler, Christian Frings, Annett Mueller, et al.
Stem Cell Reports|December 4, 2018
Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate DecisionAmanda Dalby, Jose Ballester-Beltrán, Chiara Lincetto, et al.
Translational Psychiatry|January 19, 2021
The placenta protects the fetal circulation from anxiety-driven elevations in maternal serum levels of brain-derived neurotrophic factorHayley Dingsdale, Xinsheng Nan, Samantha M Garay, et al.
Cancers|July 17, 2020
CCR2 of Tumor Microenvironmental Cells Is a Relevant Modulator of Glioma BiologyMatthäus Felsenstein, Anne Blank, Alexander D Bungert, et al.
Neuropathology and Applied Neurobiology|November 8, 2022
Myeloid cell subpopulations compensate each other for Ccr2-deficiency in glioblastomaAlexander D Bungert, Ruth M Urbantat, Claudius Jelgersma, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Emerging Topics in Life Sciences|February 1, 2021
Using genome editing to engineer universal plateletsMoyra Lawrence, Annett Mueller, Cedric Ghevaert
Immunologic Research|April 4, 2017
Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in gliomaSusan Brandenburg, Kati Turkowski, Annett Mueller, et al.
Cancer Chemotherapy and Pharmacology|May 1, 2012
Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell linesAnnett Mueller, Erika Bachmann, Monika Linnig, et al.
Glia|September 27, 2017
VEGF as a modulator of the innate immune response in glioblastomaKati Turkowski, Susan Brandenburg, Annett Mueller, et al.
International Journal of Cancer|December 30, 2009
Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathwaysOrestis Lyros, Annett Mueller, Florian Heidel, et al.
World Journal of Gastroenterology|July 19, 2008
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximabMarkus Moehler, Christian Frings, Annett Mueller, et al.
Stem Cell Reports|December 4, 2018
Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate DecisionAmanda Dalby, Jose Ballester-Beltrán, Chiara Lincetto, et al.
Translational Psychiatry|January 19, 2021
The placenta protects the fetal circulation from anxiety-driven elevations in maternal serum levels of brain-derived neurotrophic factorHayley Dingsdale, Xinsheng Nan, Samantha M Garay, et al.
Cancers|July 17, 2020
CCR2 of Tumor Microenvironmental Cells Is a Relevant Modulator of Glioma BiologyMatthäus Felsenstein, Anne Blank, Alexander D Bungert, et al.
Neuropathology and Applied Neurobiology|November 8, 2022
Myeloid cell subpopulations compensate each other for Ccr2-deficiency in glioblastomaAlexander D Bungert, Ruth M Urbantat, Claudius Jelgersma, et al.
Pageof 2